Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PAREXEL and Osaka International Cancer Institute announced that they have formed an alliance to advance clinical development in Japan.
read more
PAREXEL and Meiji Pharmaceutical University (MPU) announced a new Joint Program for Clinical Research and Clinical Trial Management for undergraduate students.
read more
Thursday, September 24, 2020
Parexel in collaboration with Innoplexus have launched the COVID-19 Clearinghouse, an online resource for patients, researchers and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials and current ...
read more
Parexel and HealthVerity have announced a strategic partnership to expand Parexel’s network of RWD sources to accelerate the delivery of drug development solutions for customers.
read more
Monday, September 17, 2018
PAREXEL and Datavant announced they are partnering to enhance clinical study design and operations, as well as the generation of real-world evidence.
read more
PAREXEL announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
read more
Parexel announced the deployment of nearly 30 employee volunteers to help administer and oversee COVID-19 testing across the UK in partnership with the ACRO.
read more
Wednesday, January 20, 2016
PAREXEL International Corporation, a global biopharmaceutical services organization, announced that the company has entered into a definitive agreement to acquire all outstanding equity securities of Health Advances, LLC, an independent life sciences...
read more
PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne R. Larson has been appointed as Vice President, ...
read more
Tuesday, February 18, 2014
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the...
read more
PAREXEL announced the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard employer.
read more
Tuesday, February 18, 2014
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL subsidiary that provides the Perceptive MyTrials® eClinical platform and other advanced ...
read more
Parexel announced its collaboration with CluePoints, a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software.
read more
Monday, September 19, 2016
PAREXEL International Corporation a global biopharmaceutical services organization, has announced the appointment of Christian Dreger, Ph.D., as Senior Vice President, PAREXEL Access and PAREXEL Consulting.
read more
Wednesday, December 13, 2017
PAREXEL introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.
read more